{
    "code": "01022197",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=01022197",
    "time": "2023-05-18 19:12:00",
    "許可證字號": "衛署藥製字第022197號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "113\/05\/25",
    "發證\/登錄日期": "69\/09\/18",
    "許可證\/登錄種類": "製　劑",
    "舊證字號": "12014597",
    "醫療器材級數": "",
    "第一等級醫療器材原許可證字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHY00102219704",
    "中文品名": "&quot;中美&quot;咳風樂內服顆粒劑",
    "英文品名": "SAUHONRO GRANULES &quot;C.M.&quot;",
    "適應症": "緩解感冒之各種症狀（流鼻水、鼻塞、打噴嚏、咽喉痛、咳嗽、喀痰、畏寒、發燒、頭痛、關節痛、肌肉酸痛）。",
    "劑型": "150內服顆粒劑",
    "包裝": "6-500包(每包2公克)鋁箔袋盒裝 12-1000公克塑膠瓶裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "17醫師藥師藥劑生指示藥品",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "CHLORPHENIRAMINE MALEATE, DL-METHYLEPHEDRINE HCL, ACETAMINOPHEN (EQ TO PARACETAMOL), ETHENZAMIDE (ETHOXYBENZAMIDE), CAFFEINE, NOSCAPINE, POTASSIUM GUAIACOLSULFONATE",
    "限制項目": "01國　產",
    "申請商名稱": "中美兄弟製藥股份有限公司",
    "申請商地址": "彰化市東芳里彰鹿路１０６號",
    "主製造廠": [
        {
            "製造廠名稱": "中美兄弟製藥股份有限公司",
            "製造廠廠址": "彰化市東芳里彰鹿路１０６號",
            "製造廠公司地址": "",
            "製造廠國別": "TAIWAN",
            "製程": ""
        }
    ],
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "0400000810",
            "成分名稱": "CHLORPHENIRAMINE MALEATE",
            "含量描述": "1.2",
            "含量": "1.2000000000",
            "單位": "MG"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "1212001813",
            "成分名稱": "DL-METHYLEPHEDRINE HCL",
            "含量描述": "5",
            "含量": "5.0000000000",
            "單位": "MG"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "2808000100",
            "成分名稱": "ACETAMINOPHEN (EQ TO PARACETAMOL)",
            "含量描述": "75",
            "含量": "75.0000000000",
            "單位": "MG"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "2808600900",
            "成分名稱": "ETHENZAMIDE (ETHOXYBENZAMIDE)",
            "含量描述": "125",
            "含量": "125.0000000000",
            "單位": "MG"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "2820000400",
            "成分名稱": "CAFFEINE",
            "含量描述": "20",
            "含量": "20.0000000000",
            "單位": "MG"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "4800002400",
            "成分名稱": "NOSCAPINE",
            "含量描述": "5",
            "含量": "5.0000000000",
            "單位": "MG"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "4800002800",
            "成分名稱": "POTASSIUM GUAIACOLSULFONATE",
            "含量描述": "30",
            "含量": "30.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "咳風樂內服顆粒劑-說-正面-107-01-11.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01022197&Seq=006&Type=9"
        },
        {
            "title": "咳風樂內服顆粒劑-說-反面-107-01-11.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01022197&Seq=005&Type=9"
        },
        {
            "title": "咳風樂內服顆粒劑-鋁-107-01-11.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01022197&Seq=010&Type=8"
        },
        {
            "title": "咳風樂內服顆粒劑-標-107-01-11.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01022197&Seq=009&Type=8"
        },
        {
            "title": "咳風樂內服顆粒劑-盒-107-01-11.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01022197&Seq=008&Type=8"
        }
    ]
}